
    
      The investigators are undertaking an open-label, single-arm, multicenter trial of adults
      patients with ITP in China. Patients with treatmant naive ITP were given ATRA treatment.
      Platelet count, bleeding and other symptoms were evaluated before and after treatment.
      Adverse events are also recorded throughout the study.
    
  